GlassScriptPhysician profile
Charles J Limb
NPI 1780629717
$12,468.14
in general payments reported to CMS, 2019-2025
9 companies · $4,769 in 2025
The $4,769 reported for 2025 was more than what 95% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $848 · 2020: $24.76 · 2021: $275 · 2022: $1,273 · 2023: $182 · 2024: $5,096 · 2025: $4,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,402 · Honoraria: $3,086 · Food and Beverage: $2,974 · Education: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,402.14 |
| Honoraria | $3,086.00 |
| Food and Beverage | $2,974.48 |
| Education | $585.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $9,866.44 | 2019-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Cochlear Americas | $1,007.35 | 2019-2025 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Advanced Bionics, LLC | $650.23 | 2019-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Iotamotion, INC. | $307.59 | 2024-2025 | Iotasoft |
| Oticon Medical, LLC | $200.37 | 2021 | |
| Stryker Corporation | $189.09 | 2024-2025 | Audion Et Dilation System, Scopis Ent, N/A |
| Amgen INC. | $153.67 | 2025 | Tavneos |
| Integra Lifesciences Corporation | $51.20 | 2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Smith+Nephew, INC. | $42.20 | 2025 | Tula |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Limb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.